| Primary |
| Hypersensitivity |
19.3% |
| Anaphylactic Reaction |
18.6% |
| Food Allergy |
10.8% |
| Allergy To Arthropod Sting |
9.8% |
| Asthma |
8.7% |
| Arthropod Sting |
7.8% |
| Hypertension |
3.5% |
| Pain |
2.8% |
| Urticaria |
2.7% |
| Depression |
2.0% |
| Dyspnoea |
2.0% |
| Cardiac Disorder |
1.8% |
| Accidental Exposure |
1.6% |
| Anaphylactic Shock |
1.4% |
| Anxiety |
1.2% |
| Blood Cholesterol Increased |
1.2% |
| Drug Hypersensitivity |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Swelling |
1.2% |
| Hypothyroidism |
1.1% |
|
| Drug Ineffective |
19.6% |
| Accidental Exposure |
19.0% |
| Injection Site Pain |
9.5% |
| Injection Site Pallor |
6.5% |
| Expired Drug Administered |
6.2% |
| Skeletal Injury |
4.4% |
| Injury Associated With Device |
4.0% |
| Tremor |
3.5% |
| Product Quality Issue |
3.0% |
| Pain |
2.7% |
| Pain In Extremity |
2.7% |
| Injection Site Haematoma |
2.5% |
| Injection Site Swelling |
2.4% |
| Vasoconstriction |
2.4% |
| Injection Site Haemorrhage |
2.2% |
| No Adverse Event |
2.2% |
| Nervousness |
2.1% |
| Loss Of Consciousness |
1.9% |
| Tachycardia |
1.7% |
| Injection Site Injury |
1.6% |
|
| Secondary |
| Hypersensitivity |
15.4% |
| Asthma |
10.9% |
| Drug Use For Unknown Indication |
8.3% |
| Gastrooesophageal Reflux Disease |
6.7% |
| Diabetes Mellitus |
6.1% |
| Migraine |
5.0% |
| Hypertension |
4.6% |
| Anaphylactic Reaction |
4.2% |
| Chest Pain |
4.2% |
| Depression |
4.2% |
| Diabetic Neuropathy |
3.8% |
| Anxiety |
3.6% |
| Food Allergy |
3.6% |
| Multiple Allergies |
3.6% |
| Muscle Spasms |
3.6% |
| Arthralgia |
3.2% |
| Fluid Retention |
3.0% |
| Allergy To Arthropod Sting |
2.4% |
| Fibromyalgia |
2.0% |
| Panic Attack |
2.0% |
|
| Drug Ineffective |
28.1% |
| Memory Impairment |
17.7% |
| Expired Drug Administered |
7.3% |
| Troponin Increased |
7.3% |
| Myocardial Infarction |
6.3% |
| Product Quality Issue |
5.2% |
| Panic Attack |
4.2% |
| Injection Site Pain |
3.1% |
| Loss Of Consciousness |
3.1% |
| Vomiting |
3.1% |
| Accidental Exposure |
2.1% |
| Injection Site Haematoma |
2.1% |
| Kounis Syndrome |
2.1% |
| Tremor |
2.1% |
| Cardiac Disorder |
1.0% |
| Dizziness |
1.0% |
| Drug Hypersensitivity |
1.0% |
| Expired Device Used |
1.0% |
| Gas Gangrene |
1.0% |
| Injection Site Bruising |
1.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.6% |
| Drug Use For Unknown Indication |
20.0% |
| Asthma |
10.4% |
| Hypersensitivity |
6.1% |
| Pain |
3.7% |
| Hypertension |
2.9% |
| Osteoporosis |
2.1% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Hereditary Angioedema |
1.7% |
| Rheumatoid Arthritis |
1.6% |
| Contraception |
1.5% |
| Anaphylactic Reaction |
1.3% |
| Anxiety |
1.3% |
| Depression |
1.3% |
| Nausea |
1.3% |
| Multiple Sclerosis |
1.2% |
| Migraine |
1.2% |
| Dyspnoea |
1.1% |
| Constipation |
1.0% |
| Blood Cholesterol Increased |
1.0% |
|
| Urticaria |
11.7% |
| Pain |
8.1% |
| Vomiting |
8.1% |
| Anaphylactic Reaction |
6.8% |
| Wheezing |
6.5% |
| Weight Decreased |
6.0% |
| Hypersensitivity |
5.7% |
| Dyspnoea |
4.9% |
| Pruritus |
4.7% |
| Tremor |
4.7% |
| Pulmonary Embolism |
4.4% |
| Asthma |
3.9% |
| Nausea |
3.9% |
| Respiratory Distress |
3.6% |
| Weight Increased |
3.6% |
| Death |
2.9% |
| Off Label Use |
2.9% |
| Myocardial Infarction |
2.6% |
| Rash |
2.6% |
| Throat Tightness |
2.6% |
|
